Lactation serves as a metabolic reset, significantly reducing long-term maternal cardiovascular disease risk

Cardiovascular disease (CVD) is the leading cause of pregnancy-related death in the US. Pregnancy acts as a profound cardiometabolic "stress test," revealing underlying susceptibilities due to significant hemodynamic and metabolic shifts, including increased plasma volume, cardiac output, a lipogenic state with elevated triglycerides and LDL, and relative insulin resistance. These changes can predispose mothers to endothelial damage and atherogenesis. Understanding strategies to mitigate this postpartum risk is crucial for long-term maternal health.

This editorial synthesized existing literature on the physiological changes in maternal cardiovascular health during the perinatal period. It reviewed the impact of pregnancy-induced cardiometabolic stress and explored the proposed protective mechanisms of lactation. The authors aimed to convey the significance of lactation as a strategy to reduce long-term cardiovascular disease risk in postpartum individuals, drawing upon recommendations from organizations like the American Academy of Pediatrics and American College of Obstetricians and Gynecologists.

Pregnancy induces substantial physiological demands, including a 40% increase in plasma volume and a 45% rise in cardiac output, alongside a lipogenic state characterized by elevated serum triglycerides and LDL, and relative insulin resistance. These adaptations, while crucial for fetal development, can increase maternal susceptibility to atherogenic predisposition and endothelial damage. The review highlights that only 40% of women demonstrate optimal cardiovascular health pre-pregnancy, exacerbating these risks.

Lactation is presented as a critical "metabolic reset" for the postpartum individual, actively counteracting the cardiometabolic stressors of pregnancy and serving as a strategy to reduce the long-term risk of cardiovascular disease.